A Novel Peroxisome Proliferator-Activated Receptor Gamma/Nuclear Factor-Kappa B Activation Pathway is Involved in the Protective Effect of Adipose-Derived Mesenchymal Stem Cells Against Ischemia-Reperfusion Lung Injury
Transplantation Proceedings · 2024
DOI: 10.1016/j.transproceed.2024.01.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Yudai Miyashita und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Thoracic Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan. Hauptthemen laut MEDLINE: Lung Injury, Mesenchymal Stem Cells, Reperfusion Injury. Die Arbeit nennt 51 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Adipose-derived stem cells (ADSCs) are well-recognized for their remarkable ability to suppress ischemia-reperfusion lung injury (IRLI). The primary objective of this investigation was to elucidate the underlying mechanism through which ADSCs exert protective effects against IRLI. METHODS: A warm hilar occlusion model in C57BL6J mice was used. Hilar occlusion was achieved for 1 hour (ischemic), and after 1 hour the occlusion was released (reperfusion) to recover for 3 hours. RNA sequencing, the physiological function, pathway activation, and expression of inflammatory cytokines were evaluated. RESULTS: Lung gas exchange and pulmonary edema were significantly improved in the IRLI/ADSCs group compared with the IRLI group. RNA sequencing results suggested that the peroxisome proliferator-activated receptor gamma (PPARγ)/nuclear factor-kappa B (NF-κB) pathway was involved in the effect of the ADSCs. Administration of a PPARγ antagonist in the IRLI/ADSC group resulted in the deterioration of the physiological function. Furthermore, the PPARγ protein expression level decreased, the NF-κB protein expression level increased, and inflammatory cytokine parameters from lung tissue and blood sample worsened in the PPARγ antagonist-administered group. CONCLUSION: Administration of ADSCs exerted a significant protective effect against IRLI in mice, and the effect is attributed to the activation of the PPARγ/NF-κB pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Thoracic Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
- Department of General Thoracic Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan. Electronic address: kanoutakashi0999@yahoo.co.jp.
- Department of Pathology, Graduate School of Medicine, Osaka University, Osaka, Japan.
Zitieren
APA
Miyashita, Y., Kanou, T., Fukui, E., Matsui, T., Kimura, T., Ose, N., Funaki, S., & Shintani, Y. (2024). A Novel Peroxisome Proliferator-Activated Receptor Gamma/Nuclear Factor-Kappa B Activation Pathway is Involved in the Protective Effect of Adipose-Derived Mesenchymal Stem Cells Against Ischemia-Reperfusion Lung Injury. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.01.003
Vancouver
Miyashita Y, Kanou T, Fukui E, Matsui T, Kimura T, Ose N, et al. A Novel Peroxisome Proliferator-Activated Receptor Gamma/Nuclear Factor-Kappa B Activation Pathway is Involved in the Protective Effect of Adipose-Derived Mesenchymal Stem Cells Against Ischemia-Reperfusion Lung Injury. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.01.003
BibTeX
@article{Miyashita2024,
author = {Miyashita, Yudai and Kanou, Takashi and Fukui, Eriko and Matsui, Takahiro and Kimura, Toru and Ose, Naoko and Funaki, Soichiro and Shintani, Yasushi},
title = {A Novel Peroxisome Proliferator-Activated Receptor Gamma/Nuclear Factor-Kappa B Activation Pathway is Involved in the Protective Effect of Adipose-Derived Mesenchymal Stem Cells Against Ischemia-Reperfusion Lung Injury},
journal = {Transplantation Proceedings},
year = {2024},
doi = {10.1016/j.transproceed.2024.01.003}
}
EUVIMED